Table of Contents
<< Previous Issue | Jan 2013 (Vol: 2013, Issue: 1) | Next Issue >> |
- Section: Joint Venture
-
Teva Forms Joint Venture with Handok Pharmaceuticals to Tap South Korean Market
- Section: Licensing
-
Dutch Start-Up Dezima Pharma In-Licenses First Pipeline Drug from Mitsubishi Tanabe
- Section: Mergers & Acquisitions
-
Pernix Therapeutics Agrees to Buy Beleaguered Somaxon Pharmaceuticals
-
The Medicines Company Strengthens its Perioperative Care Franchise via Deals with Incline Therapeutics and BMS
-
Gilead to Strengthen Oncology Pipeline with YM BioSciences Purchase
-
Allergan Looks to Boost Migraine Business with MAP Pharmaceuticals Purchase
- Section: Research & Development
-
Celgene Signs US$500 M Next-Generation Antibody Deal with Sutro Biopharma
-
Halozyme’s Enhanze™ Technology Gains Much-Needed Boost with Pfizer Collaboration
-
MacroGenics Gains Another DART™ Collaborator in Gilead
-
Amgen Invests in Nanomedicine with BIND Biosciences Collaboration
-
AstraZeneca and Vanderbilt University Partner to Develop Drugs for Major Brain Disorders